iShares Healthcare Innovation UCITS ETF USD (Acc)

The Fund aims to achieve a return on your investment, through a combination of capital growth and income on the Fund's assets, which reflects the return of the STOXX Global Breakthrough Healthcare Index, the Fund's benchmark index (the Index) The Fund is passively managed, and aims to invest in equity securities (e.g. shares) that, so far as possible and practicable, make up the Index. The Index reflects the performance of a subset of global equity securities within the STOXX Global Total Market Index ("Parent Index") which derive significant revenues from healthcare innovation. Companies included in the Index must generate at least 50% (45% for existing companies included in the Index) of their annual revenues from sectors associated with the healthcare innovation theme, such as generic drugs, immunotherapy (e.g. stem cell treatment) and healthcare IT. Further details are available on the index provider's website at https://www.stoxx.com/indices. The Index excludes companies from the Parent Index which are identified by the index provider as being involved in certain business lines/activities, as outlined in the Fund's Prospectus. The Fund's investment in securities that make up the Index will, at the time of purchase, comply with the credit or ESG requirements of the Index. Where securities no longer meet such requirements, the Fund may continue to hold them until they cease to form part of the Index and it is practicable to sell them. The Fund will take into account such ESG criteria only when selecting the securities to be held directly by the Fund. The Fund may obtain indirect exposure (for example, through financial derivative instruments ("FDIs") (i.e. investments the prices of which are based on one or more underlying assets) and units in collective investment schemes) to securities considered not to satisfy these ESG criteria. Each constituent of the Index is equally weighted. The Fund uses optimising techniques to achieve a similar return to its Index. The

Optimized sampling

PIR compliant

No

PEA compliant

No

PEA-PME compliant

No